Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
TriPRIL CAR T Cells in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Bisantrene Combination for Resistant AML
- Status
- RECRUITING
- Phase
- PHASE2
Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
- Status
- COMPLETED
- Phase
- PHASE2